Kim Namou

Namou Kim, MD

  • Otolaryngology
  • Head and Neck Surgery
  • Facial Plastic Surgery
Accepting New Patients
1101 Madison St.
Suite 850
Seattle, WA 98104

General Information


Position Summary Director, Head & Neck and Reconstructive Surgery, Swedish Medical Center
Additional Information


Clinical Program Leader, Swedish Cancer Institute Head & Neck Program (present)

Director, Head & Neck and Reconstructive Surgery, Swedish Medical Center (present)

Clinical Instructor, General Surgery Residency Program Swedish Medical Center (present)

Consultant and Surgeon, Department of Otolaryngology, Head & Neck Surgery, Mayo Clinic Arizona,  (2004-2009)

Funding, Award, Honor

““Dr. Kim was voted "Top Doctors" in Seattle Metropolitan Magazine (2012)

Nearly 4,500 physicians, nurses and physician assistants in King, Kitsap and Snohomish counties nominated colleagues they would choose to treat themselves and their loved ones.

News Release

Conference Co-Chair. Pacific Northwest Head and Neck Cancer Symposium. University of Washington School of Medicine and Swedish Medical Center. Seattle, WA. April 1st, (2011)

Teacher of the Year Award 2010-2011. Swedish Medical Center General Surgery Residency (2011)

Conference Chair. Swedish Cancer Institute Annual Oncology Symposium: Head & Neck. Seattle, WA. May 7th, (2010)

Mayo Clinic Foundation Grant “Comparison of Anti-Thrombotic Effects of Aspirin, Ketorolac, and Low Molecular Weight Heparin in Rats Set Up for Microvascular Failure” (2008)


Patient Story - Bill Garber with Laryngeal Cancer

Head and Neck Surgery Overview Video


Head & Neck Surgery Newsletters


Annual Northwest Pacific Head and Neck Cancer Symposium (2010, 2011, 2012, 2013)

Annualy Oncology Symposium - Head and Neck Cancer (Swedish Cancer Institute) (2010)

  • Head and Neck Surgery
  • Otolaryngology
Education Background
Medical School: Cleveland Clinic Lerner College of Medicine, 1998
Medical School: Case Western Reserve University
Residency: Case Western Reserve University, 2003
Fellowship: Mayo Clinic, Head & Neck Oncologic and Microvascular Surgery, 2004
  • English
  • French
  • Korean




Oda D, Kim N, Mollen D. Diffuse and Deep Ulceration of Tongue. The Washington State Dental News 2011;8:37.

Harsha W, Kau R, Kim N, Hayden R. Comparison of Anti-Thrombotic Effects of Aspirin, Ketorolac, and Low Molecular Weight Heparin in Rats Set Up for Microvascular Failure. Arch Otolaryngol Head Neck Surg 2011;137:170-174.

Makowski R, Kim N. Rib and Costal Cartilage Necrosis Following Pec Major Flap Harvest. Submitted for review in Head & Neck in December 2011.

Kau R, Kim N, Patel N, Hinni M. Repair of Esophageal Perforation Due to Anterior Cervical Spine Instrumentation. Laryngoscope 2010;120(4):739-742.

Wise S, Harsha W, Kim N, Hayden R. Free Flap Survival Despite Early Loss of the Vascular Pedicle. Head Neck, n/a. doi: 10.1002/hed.21354 (e-pub ahead of publication).

Yoo M, Kim N, Houser S. Natural Draining Osteum of an Agger Nasi Cell. Ear Nose Throat J 2004;83:399-403.

Kim N, Lavertu P. Evaluation of a Thyroid Nodule. Otolaryngol Clin N Am 2003;36:17-33.


Management of Tongue Cancers. N. Kim. Oral Cancer Foundation. Seattle, WA. September 2011.

Contemporary Reconstruction of Laryngopharyngeal Defects. N. Kim. 25th Annual Madigan Head & Neck Surgery Seminar. Tacoma, WA. August 2011. Cat I CME.

Side Effects of Modern Chemoradiation in Head & Neck Cancer. N. Kim. 25th Annual Madigan Head & Neck Surgery Seminar. Tacoma, WA. August 2011. Cat I CME.

Management of Osteoradionecrosis. N. Kim. Pacific Northwest Head, Neck, and Thyroid Cancer Symposium. Seattle, WA. April 2011. Cat I CME.

Complications of Chemo and Radiation Therapy. N. Kim. Northwest Academy of Otolaryngology and Washington State Medical Association Winter 2011 Conference. Seattle, WA. January 2011. Cat I CME.

Reconstruction of Orbitomaxillary Defects. N. Kim. Swedish Neurosciences Institute ENT Exploratorium. Seattle, WA. October 2010. Cat II CME.


Good nutrition crucial before head and neck cancer therapy

February 26, 2016

Good nutrition is crucial for any patient undergoing cancer therapy, but many head and neck cancer patients struggle to get the nutrients they need as they prepare for treatment. A large proportion of patients with head and neck cancers present to their doctors with significant weight loss. Sometimes, the weight loss is unexplained. But more often, there is a clear reason for it.

HPV-induced "throat cancer" and the difficult questions

January 27, 2016

Head and neck cancers commonly refer to malignant tumors originating in the tongue and throat region. Traditionally, those cancers were caused by long-term tobacco use and high alcohol consumption. But in the past three decades, more and more of these cancers have a new cause.

Importance of swallow exercises during throat cancer treatment

December 15, 2014
In the past decade, there has been a significant increase of “throat” cancers (tonsil and base of tongue squamous cell carcinoma) in younger patients, especially in non-smoking, Caucasian males. This type of cancer is caused by the high-risk HPV (Human Papilloma Virus) and tends to have a better cancer survival than conventional tobacco-related throat cancers. This improved survival is aided by precision targeted radiation and transoral robotic surgery (DaVinci Robotic System). However, some of the side effects of these treatments can cause ...

Subtle, early symptoms of head & neck cancer

November 26, 2014
Patients often ask me how long they have had the cancers that they are consulting me for. This question is not intended to shift any responsibility nor accountability, but patients are genuinely trying to understand what they could have done differently. Although the treatment course would not have changed regardless, there were probably some early subtle symptoms that patients might have ignored:

Bisphosphonate medications and Osteonecrosis of the jaw

December 06, 2013

Bisphosphonate use has been increasing in recent years.  This is a class of medications that is used to solidify bone mass and prevent fractures.  They fight osteoporosis, but also prevent many cancers from spreading into skeletal bones (bone metastases).  Many patients with metastatic cancers (breast, prostate, renal cell, multiple myeloma, etc.) will require these medications to counteract the devastating consequences of bone metastases.

Bisphosphonates were described as early as the 19th century, and were approved by the FDA in the 1990s for human use.  Fosamax was the first FDA approved bisphosphonate in the USA.   The medications come in an oral (pill) form and an IV version.  Other commonly prescribed bisphosphonates include:

  1. Zometa  (Zolendronate)
  2. Actonel  (Risedronate)
  3. Boniva  (Ibandronate)
  4. Aredia  (Pamidronate)

An uncommon but significant potential side effect o...

Neck lump or mass

September 20, 2013

A palpable neck lump in any patient should raise some concern.  In the case of a pediatric patient, the concern may be less, since reactive and infectious nodes in the neck can be fairly common in children.  When a child has a bad episode of pharyngitis, tonsillitis (sore throat), or even a bad cold, the lymph nodes of the neck may react and become enlarged.  In that type of scenario, your doctor should prescribe appropriate antibiotics to resolve the enlarged lymph nodes and follow up to make sure that the nodes have regressed.

Very few pediatric neck masses will end up being concerning.  Besides infectious neck lymph nodes as stated above, some of the other more common causes of pediatric neck mass are congenital cysts.  However, none of the pediatric neck masses should be ignored.  A neck lump that persists for more than a few days should be looked at by a pediatrician.

In the adult population, a neck mass or lump can be much more concerning.  ...

Cutting Edge Concept in the Treatment of tongue, tonsil, and throat cancer

May 21, 2011

Cancers of the tongue, tonsil, and throat are being diagnosed at an increasing rate, even in the non-smoking population. Transoral Laser Microsurgery (TLM) and Trans Oral Robotic Surgery (TORS) are some of the newest intervention available for patients with these cancers.


During my first 3 years of medical school in Cleveland, I frankly did not know anything about cancers of the mouth and throat (otherwise called "Head & Neck Cancer").  Really, I did not know you could get cancer in the tongue or tonsil!  It wasn't until the final year of medical school that I was exposed to the field of Head & Neck Surgery, that I realize the impact of these cancers on the quality of life of patients.

Those cancers are generally not featured in the media, and I would argue that most of us will live a lifetime without meet...

Clinical Experience

1101 Madison St.
Suite 850
Seattle, WA 98104